• Publications
  • Influence
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
BACKGROUND The efficacy of thiazolidinediones, as compared with other oral glucose-lowering medications, in maintaining long-term glycemic control in type 2 diabetes is not known. METHODS WeExpand
  • 2,648
  • 113
  • PDF
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
OBJECTIVE—The effectiveness of intentional weight loss in reducing cardiovascular disease (CVD) events in type 2 diabetes is unknown. This report describes 1-year changes in CVD risk factors in aExpand
  • 1,339
  • 48
  • PDF
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Background—The National Cholesterol Education Program (NCEP) recently proposed a simple definition for metabolic syndrome. Information on the prospective association of this definition for coronaryExpand
  • 1,516
  • 45
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
Although the individual components of the metabolic syndrome are clearly associated with increased risk for coronary heart disease (CHD), we wanted to quantify the increased prevalence of CHD amongExpand
  • 1,422
  • 43
  • PDF
The prevalence of diabetic retinopathy among adults in the United States.
OBJECTIVE To determine the prevalence of diabetic retinopathy among adults 40 years and older in the United States. METHODS Pooled analysis of data from 8 population-based eye surveys was used toExpand
  • 929
  • 41
  • PDF
The Homeostasis Model in the San Antonio Heart Study
OBJECTIVE Both insulin resistance and decreased insulin secretion have been shown to predict the development of NIDDM. However, methods to assess insulin sensitivity and secretion are complicated andExpand
  • 740
  • 39
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
BACKGROUND Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events. METHODS We randomlyExpand
  • 1,805
  • 37
  • PDF
The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial
Context Intensive diet and exercise or metformin can prevent the development of diabetes in individuals with impaired fasting glucose, but the effects of these interventions on development of theExpand
  • 879
  • 33
  • PDF
Global prevalence and major risk factors of diabetic retinopathy.
Yau, JW; Rogers, SL; Kawasaki, R; Lamoureux, EL; Kowalski, JW; Bek, T; Chen, SJ; Dekker, JM; Fletcher, A; Grauslund, J; +27 more... Haffner, S; Hamman, RF; Ikram, MK; Kayama, T; Klein, BE; Klein, R;Expand
  • 333
  • 31
  • PDF
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
BACKGROUND Type 2 (non-insulin-dependent) diabetes is associated with a marked increase in the risk of coronary heart disease. It has been debated whether patients with diabetes who have not hadExpand
  • 3,165
  • 28